ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Johnson & Johnson's fourth-quarter drug sales rise 5.3 percent, led by Stelara, Imbruvica, Darzalex
January 22, 2019Credit Suisse analyst Vamil Divan noted that Johnson & Johnson's quarterly profit was boosted by from an effective tax rate of 2.6 percent, amounting to just $80 million. Meanwhile, J.P. Morgan analyst Chris Schott said the positive outlook for the compan -
Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance
February 01, 2018Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2017.
Pharma Sources Insight January 2025
